GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinco Pharmaceutical Holdings Ltd (HKSE:06833) » Definitions » Cyclically Adjusted PS Ratio

Sinco Pharmaceutical Holdings (HKSE:06833) Cyclically Adjusted PS Ratio : 0.22 (As of Jun. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sinco Pharmaceutical Holdings Cyclically Adjusted PS Ratio?

As of today (2024-06-05), Sinco Pharmaceutical Holdings's current share price is HK$0.236. Sinco Pharmaceutical Holdings's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was HK$1.08. Sinco Pharmaceutical Holdings's Cyclically Adjusted PS Ratio for today is 0.22.

The historical rank and industry rank for Sinco Pharmaceutical Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

HKSE:06833' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.21   Med: 0.23   Max: 0.27
Current: 0.22

During the past 10 years, Sinco Pharmaceutical Holdings's highest Cyclically Adjusted PS Ratio was 0.27. The lowest was 0.21. And the median was 0.23.

HKSE:06833's Cyclically Adjusted PS Ratio is ranked better than
67.69% of 65 companies
in the Medical Distribution industry
Industry Median: 0.38 vs HKSE:06833: 0.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sinco Pharmaceutical Holdings's adjusted revenue per share data of for the fiscal year that ended in Dec23 was HK$1.367. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is HK$1.08 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sinco Pharmaceutical Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sinco Pharmaceutical Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinco Pharmaceutical Holdings Cyclically Adjusted PS Ratio Chart

Sinco Pharmaceutical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.22

Sinco Pharmaceutical Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.22

Competitive Comparison of Sinco Pharmaceutical Holdings's Cyclically Adjusted PS Ratio

For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinco Pharmaceutical Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sinco Pharmaceutical Holdings's Cyclically Adjusted PS Ratio falls into.



Sinco Pharmaceutical Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sinco Pharmaceutical Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.236/1.08
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinco Pharmaceutical Holdings's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Sinco Pharmaceutical Holdings's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=1.367/114.7809*114.7809
=1.367

Current CPI (Dec23) = 114.7809.

Sinco Pharmaceutical Holdings Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.992 99.000 1.150
201512 1.098 100.600 1.253
201612 0.627 102.600 0.701
201712 0.592 104.500 0.650
201812 0.641 106.500 0.691
201912 0.774 111.200 0.799
202012 1.436 111.500 1.478
202112 1.426 113.108 1.447
202212 1.249 115.116 1.245
202312 1.367 114.781 1.367

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sinco Pharmaceutical Holdings  (HKSE:06833) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sinco Pharmaceutical Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinco Pharmaceutical Holdings (HKSE:06833) Business Description

Traded in Other Exchanges
N/A
Address
No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN
Sinco Pharmaceutical Holdings Ltd is an investment holding company engaged in the provision of comprehensive marketing, promotion, and channel management service for imported pharmaceutical products and medical devices in China. The company has three operating segments; the sale of imported pharmaceutical products segment, the research and manufacturing of aesthetic medicine segment, and the medical beauty services segment. Its product offering includes Human albumin solutions and Antibiotics like Axetine and Medocef.
Executives
Huang Zhijian 2305 Beneficiary of a trust
Fullwealth Holdings Limited 2201 Interest of corporation controlled by you
Risun Investments Limited 2101 Beneficial owner
Wickhams Cay Trust Company Limited 2301 Trustee
Huang Xiangbin 2307 Founder of a discretionary trust who can infl

Sinco Pharmaceutical Holdings (HKSE:06833) Headlines

No Headlines